|
Volumn 306, Issue 13, 2011, Pages 1479-1480
|
The medical benefits of male circumcision
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AFRICA;
CIRCUMCISION;
COST EFFECTIVENESS ANALYSIS;
HEALTH CARE CONCEPTS;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HIGH RISK POPULATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION PREVENTION;
MEDICAID;
MEDICAL BENEFIT;
NOTE;
PREVALENCE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
SEXUAL SATISFACTION;
SEXUALLY TRANSMITTED DISEASE;
UNITED STATES;
ADOLESCENT;
ARTICLE;
COST BENEFIT ANALYSIS;
ECONOMICS;
FEMALE;
HETEROSEXUALITY;
INFORMED CONSENT;
INSURANCE;
MALE;
MEDICAL ETHICS;
MICROBIOLOGY;
NEWBORN;
PENIS TUMOR;
RISK;
UTERINE CERVIX TUMOR;
VIROLOGY;
ADOLESCENT;
AFRICA;
CIRCUMCISION, MALE;
COST-BENEFIT ANALYSIS;
ETHICS, MEDICAL;
FEMALE;
HETEROSEXUALITY;
HIV INFECTIONS;
HUMANS;
INFANT, NEWBORN;
INFORMED CONSENT;
INSURANCE COVERAGE;
MALE;
MEDICAID;
PENILE NEOPLASMS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK;
SEXUALLY TRANSMITTED DISEASES;
UNITED STATES;
UTERINE CERVICAL NEOPLASMS;
|
EID: 80053531644
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2011.1431 Document Type: Note |
Times cited : (96)
|
References (10)
|